查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1762357

製劑開發外包市場，規模，佔有率，產業分析報告:各製劑，各類服務，各治療領域，各最終用途，各地區，2025年～2034年的市場預測

Formulation Development Outsourcing Market Size, Share, & Industry Analysis Report: By Formulation, By Service (Preformulation and Formulation Development), By Therapeutic Area, By End Use, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，製劑開發外包市場規模預計到2034年將達到835.5億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

製劑開發外包市場涉及將臨床前和臨床階段的製劑活動外包給專業的合約研究與生產組織 (CDMO) 和合約研發組織 (CRO)。這些服務支持製藥和生物製藥公司優化活性藥物成分 (API) 的遞送、穩定性和生物利用度，尤其是針對複雜且難溶性化合物。由於藥物研發管線中分子複雜性的不斷增加、對專業遞送系統的需求不斷增長，以及在成本限制下縮短開發時間的需求，該市場正在經歷持續增長。外包已成為取得奈米製劑、緩釋平台和溶解度增強技術等先進技術的關鍵，而這些技術通常內部維護成本高。影響該行業的關鍵趨勢是將製劑開發整合到涵蓋藥物發現到商業化的廣泛端到端服務模式中。此外，預測模型、高通量篩選和數據驅動製劑分析的引入正在改變製劑決策的方式，從而降低失敗率並縮短週期。

高度客製化的小批量生產製劑需要敏捷且技術精湛的外包合作夥伴。日益嚴格的監管審查迫使供應商採用穩健的QbD和基於風險的方法，進一步提升其策略價值。數位化、模組化的服務交付以及對即時批次監控的日益重視預計將重塑客戶與供應商的關係，並重新定義績效和合規基準。市場變革的驅動力在於科學創新以及在日益複雜的治療和監管環境中對營運靈活性的策略需求。

製劑開發外包市場報告重點

按治療領域劃分，預計腫瘤學將在2024年佔據最大佔有率，這得益於精準腫瘤藥物需求的激增以及臨床研發管線的快速擴張。

按最終用途劃分，預計政府和學術部門在預測期內的複合年增長率最高，這得益於其在轉化研究和早期藥物發現中的作用日益增強。

按最終用途劃分，預計亞太地區將在2024年佔據最大佔有率，這得益於生物製藥創新的激增和仿製藥的快速擴張。

預計北美製劑開發外包市場將在預測期內的複合年增長率最高，這得益於生物風險投資的激增。

全球主要市場參與者包括 Catalent、Charles River Laboratories International、Element、Eurofins Scientific、Intertek Group、LabCorp、Lonza、Resipharm、SGS S.A. 和 Thermo Fisher Scientific。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 製劑開發外包市場洞察

  • 市場概述
  • 製劑開發外包市場動態
    • 促進因素和機會
      • 生物製藥和仿製藥開發的成長
      • 製劑技術的進步
    • 阻礙因素與課題
      • 智慧財產權 (IP) 與資料安全問題
  • PESTEL分析
  • 製劑開發外包市場力量強度的評估趨勢
  • 價值鏈分析

第5章 製劑開發外包市場:各製劑

  • 主要調查結果
  • 簡介
  • 口服
  • 注射
  • 外用
  • 其他

第6章 製劑開發外包市場:各類服務

  • 主要調查結果
  • 簡介
  • 處方前
  • 處方開發

第7章 製劑開發外包市場:各治療領域

  • 主要調查結果
  • 簡介
  • 腫瘤學
  • 感染疾病
  • 神經學
  • 血液學
  • 呼吸系統
  • 心血管系統
  • 皮膚科
  • 其他

第8章 製劑開發外包市場:各最終用途

  • 主要調查結果
  • 簡介
  • 製藥公司及生物醫藥品公司
  • 政府機關及學術機構
  • 其他

第9章 製劑開發外包市場:各地區

  • 主要調查結果
  • 簡介
    • 製劑開發外包市場評估:各地區，2020～2034年
  • 北美
    • 北美:各配方，2020～2034年
    • 北美:各類服務，2020～2034年
    • 北美:各最終用途，2020～2034年
    • 北美:各治療領域，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:處方，2020～2034年
    • 歐洲:各類服務，2020～2034年
    • 歐洲:各最終用途，2020～2034年
    • 歐洲:各治療領域，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各製劑，2020～2034年
    • 亞太地區:各類服務，2020～2034年
    • 亞太地區:各最終用途，2020～2034年
    • 亞太地區:各治療領域，2020年～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各製劑，2020～2034年
    • 中東·非洲:各類服務，2020～2034年
    • 中東·非洲:各最終用途，2020～2034年
    • 中東·非洲:各治療領域，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲
  • 南美
    • 南美:各製劑，2020～2034年
    • 南美:各類服務，2020～2034年
    • 南美:各最終用途，2020～2034年
    • 南美:各治療領域，2020-2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第10章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第11章 企業簡介

  • Catalent Inc.
  • Charles River Laboratories International, Inc.
  • Element
  • Eurofins Scientific SE
  • Intertek Group plc
  • Labcorp
  • Lonza
  • Recipharm
  • SGS S.A.
  • Thermo Fisher Scientific, Inc.
Product Code: PM5691

The formulation development outsourcing market size is expected to reach USD 83.55 billion by 2034, according to a new study by Polaris Market Research. The report "Formulation Development Outsourcing Market Size, Share, & Industry Analysis Report: By Formulation, By Service (Preformulation and Formulation Development), By Therapeutic Area, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The formulation development outsourcing market encompasses the externalization of preclinical and clinical-stage formulation activities to specialized contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs). These services support pharmaceutical and biopharmaceutical companies in optimizing the delivery, stability, and bioavailability of active pharmaceutical ingredients (APIs), particularly for complex and poorly soluble compounds. The market is witnessing sustained growth driven by increasing molecular complexity in drug pipelines, rising demand for specialized delivery systems, and the need for accelerated development timelines under cost constraints. Outsourcing has become essential for enabling access to advanced capabilities such as nanoformulation, sustained-release platforms, and solubility enhancement technologies, which are often cost-prohibitive to maintain in-house. A significant trend shaping the industry is the integration of formulation development into broader end-to-end service models that span from discovery to commercialization. Additionally, the deployment of predictive modeling, high-throughput screening, and data-driven formulation analytics is transforming how formulation decisions are made, reducing failure rates and cycle times.

Industry growth opportunities are expanding in the area of personalized medicine, where small-batch, highly tailored formulations require agile and technologically equipped outsourcing partners. Increasing regulatory scrutiny is pushing providers to adopt robust QbD and risk-based methodologies, further enhancing their strategic value. The growing emphasis on digitalization, modular service delivery, and real-time batch monitoring is expected to reshape client-provider relationships and redefine benchmarks for performance and compliance. The market's evolution is being driven by scientific innovation and the strategic need for operational flexibility in an increasingly complex therapeutic and regulatory landscape.

Formulation Development Outsourcing Market Report Highlights

By therapeutic area, in 2024, the oncology segment held the largest share due to the surge in demand for precision oncology therapeutics and the rapid pace of clinical pipeline expansion.

Based on end use, the government and academic institutes segment is expected to witness the highest CAGR during the forecast period due to their expanding role in translational research and early-stage drug discovery.

In 2024, Asia Pacific held the largest share due to a surge in regional biopharmaceutical innovation and rapidly expanding generics industry.

The North America formulation development outsourcing market is projected to register the highest CAGR during the forecast period, driven by an upsurge in biotech venture capital.

A few global key market players include Catalent Inc.; Charles River Laboratories International, Inc.; Element; Eurofins Scientific SE; Intertek Group plc; Labcorp; Lonza; Recipharm; SGS S.A.; and Thermo Fisher Scientific, Inc.

Polaris Market Research has segmented the market report on the basis of formulation, service, therapeutic area, end use, and region:

By Formulation Outlook (Revenue, USD Billion, 2020-2034)

Oral

Injectable

Topical

Others

By Service Outlook (Revenue, USD Billion, 2020-2034)

Preformulation

Formulation Development

By Therapeutic Area Outlook (Revenue, USD Billion, 2020-2034)

Oncology

Infectious Disease

Neurology

Hematology

Respiratory

Cardiovascular

Dermatology

Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Pharmaceutical and Biopharmaceutical Companies

Government and Academic Institutes

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Formulation Development Outsourcing Market Insights

  • 4.1. Formulation Development Outsourcing Market - Market Snapshot
  • 4.2. Formulation Development Outsourcing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growth in Biopharmaceutical and Generic Drug Development
      • 4.2.1.2. Advancements in Formulation Technologies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Intellectual Property (IP) and Data Security Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Formulation Development Outsourcing Market Power Rating Trends
  • 4.6. Value Chain Analysis

5. Formulation Development Outsourcing Market, by Formulation

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Formulation Development Outsourcing Market, by Formulation, 2020-2034 (USD Billion)
  • 5.3. Oral
    • 5.3.1. Formulation Development Outsourcing Market, by Oral, by Region, 2020-2034 (USD Billion)
  • 5.4. Injectable
    • 5.4.1. Formulation Development Outsourcing Market, by Injectable, by Region, 2020-2034 (USD Billion)
  • 5.5. Topical
    • 5.5.1. Formulation Development Outsourcing Market, by Topical, by Region, 2020-2034 (USD Billion)
  • 5.6. Others
    • 5.6.1. Formulation Development Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)

6. Formulation Development Outsourcing Market, by Service

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • 6.3. Preformulation
    • 6.3.1. Formulation Development Outsourcing Market, by Preformulation, by Region, 2020-2034 (USD Billion)
  • 6.4. Formulation Development
    • 6.4.1. Formulation Development Outsourcing Market, by Formulation Development, by Region, 2020-2034 (USD Billion)

7. Formulation Development Outsourcing Market, by Therapeutic Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 7.3. Oncology
    • 7.3.1. Formulation Development Outsourcing Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 7.4. Infectious Disease
    • 7.4.1. Formulation Development Outsourcing Market, by Infectious Disease, by Region, 2020-2034 (USD Billion)
  • 7.5. Neurology
    • 7.5.1. Formulation Development Outsourcing Market, by Neurology, by Region, 2020-2034 (USD Billion)
  • 7.6. Hematology
    • 7.6.1. Formulation Development Outsourcing Market, by Hematology, by Region, 2020-2034 (USD Billion)
  • 7.7. Respiratory
    • 7.7.1. Formulation Development Outsourcing Market, by Respiratory, by Region, 2020-2034 (USD Billion)
  • 7.8. Cardiovascular
    • 7.8.1. Formulation Development Outsourcing Market, by Cardiovascular, by Region, 2020-2034 (USD Billion)
  • 7.9. Dermatology
    • 7.9.1. Formulation Development Outsourcing Market, by Dermatology, by Region, 2020-2034 (USD Billion)
  • 7.10. Others
    • 7.10.1. Formulation Development Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)

8. Formulation Development Outsourcing Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 8.3. Pharmaceutical and Biopharmaceutical Companies
    • 8.3.1. Formulation Development Outsourcing Market, by Pharmaceutical and Biopharmaceutical Companies, by Region, 2020-2034 (USD Billion)
  • 8.4. Government and Academic Institutes
    • 8.4.1. Formulation Development Outsourcing Market, by Government and Academic Institutes, by Region, 2020-2034 (USD Billion)
  • 8.5. Others
    • 8.5.1. Formulation Development Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)

9. Formulation Development Outsourcing Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Formulation Development Outsourcing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Formulation Development Outsourcing Market - North America
    • 9.3.1. North America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.3.2. North America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.3.3. North America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.4. North America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.3.5. Formulation Development Outsourcing Market - US
      • 9.3.5.1. US: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.3.6. Formulation Development Outsourcing Market - Canada
      • 9.3.6.1. Canada: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.4. Formulation Development Outsourcing Market - Europe
    • 9.4.1. Europe: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.5. Formulation Development Outsourcing Market - UK
      • 9.4.5.1. UK: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.6. Formulation Development Outsourcing Market - France
      • 9.4.6.1. France: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.7. Formulation Development Outsourcing Market - Germany
      • 9.4.7.1. Germany: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.8. Formulation Development Outsourcing Market - Italy
      • 9.4.8.1. Italy: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.9. Formulation Development Outsourcing Market - Spain
      • 9.4.9.1. Spain: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.10. Formulation Development Outsourcing Market - Netherlands
      • 9.4.10.1. Netherlands: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.11. Formulation Development Outsourcing Market - Russia
      • 9.4.11.1. Russia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.12. Formulation Development Outsourcing Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.5. Formulation Development Outsourcing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.5. Formulation Development Outsourcing Market - China
      • 9.5.5.1. China: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.6. Formulation Development Outsourcing Market - India
      • 9.5.6.1. India: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.7. Formulation Development Outsourcing Market - Malaysia
      • 9.5.7.1. Malaysia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.8. Formulation Development Outsourcing Market - Japan
      • 9.5.8.1. Japan: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.9. Formulation Development Outsourcing Market - Indonesia
      • 9.5.9.1. Indonesia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.10. Formulation Development Outsourcing Market - South Korea
      • 9.5.10.1. South Korea: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.11. Formulation Development Outsourcing Market - Australia
      • 9.5.11.1. Australia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.12. Formulation Development Outsourcing Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.6. Formulation Development Outsourcing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.5. Formulation Development Outsourcing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.6. Formulation Development Outsourcing Market - UAE
      • 9.6.6.1. UAE: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.7. Formulation Development Outsourcing Market - Israel
      • 9.6.7.1. Israel: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.8. Formulation Development Outsourcing Market - South Africa
      • 9.6.8.1. South Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.9. Formulation Development Outsourcing Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.7. Formulation Development Outsourcing Market - Latin America
    • 9.7.1. Latin America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.5. Formulation Development Outsourcing Market - Mexico
      • 9.7.5.1. Mexico: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.6. Formulation Development Outsourcing Market - Brazil
      • 9.7.6.1. Brazil: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.7. Formulation Development Outsourcing Market - Argentina
      • 9.7.7.1. Argentina: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.8. Formulation Development Outsourcing Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Catalent Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Charles River Laboratories International, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Element
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Eurofins Scientific SE
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Intertek Group plc
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Labcorp
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Lonza
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Recipharm
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. SGS S.A.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Thermo Fisher Scientific, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development

List of Tables:

  • Table 1 Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 2 Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 3 Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 4 Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 5 North America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 6 North America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 7 North America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 8 North America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 9 US: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 10 US: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 11 US: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 12 US: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 13 Canada: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 14 Canada: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 15 Canada: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 Canada: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 17 Europe: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 18 Europe: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 19 Europe: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 20 Europe: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 21 UK: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 22 UK: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 23 UK: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 24 UK: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 25 France: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 26 France: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 27 France: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 28 France: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 29 Germany: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 30 Germany: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 31 Germany: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 32 Germany: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 33 Italy: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 34 Italy: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 35 Italy: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 36 Italy: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 37 Spain: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 38 Spain: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 39 Spain: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 40 Spain: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 45 Russia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 46 Russia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 47 Russia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 48 Russia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 57 China: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 58 China: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 59 China: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 60 China: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 61 India: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 62 India: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 63 India: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 64 India: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 69 Japan: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 70 Japan: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 71 Japan: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 72 Japan: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 77 South Korea: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 78 South Korea: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 79 South Korea: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 80 South Korea: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 81 Australia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 82 Australia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 83 Australia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 84 Australia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 97 UAE: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 98 UAE: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 99 UAE: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 100 UAE: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 101 Israel: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 102 Israel: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 103 Israel: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 104 Israel: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 105 South Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 106 South Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 107 South Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 108 South Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 113 Latin America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 114 Latin America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 115 Latin America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 116 Latin America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 117 Mexico: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 118 Mexico: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 119 Mexico: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 120 Mexico: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 121 Brazil: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 122 Brazil: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 123 Brazil: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 124 Brazil: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 125 Argentina: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 126 Argentina: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 127 Argentina: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 128 Argentina: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Formulation Development Outsourcing Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Formulation
  • Figure 7. Formulation Development Outsourcing Market, By Formulation, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Service
  • Figure 9. Formulation Development Outsourcing Market, By Service, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Formulation Development Outsourcing Market, by End Use, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Therapeutic Area
  • Figure 13. Formulation Development Outsourcing Market, by Therapeutic Area, 2024 & 2034 (USD Billion)